Drugs / OmegaD
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02980224 | Oct 2016 → Feb 2017 | dry eye syndrome | OmegaD LLC | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | OmegaD | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02980224 ↗ |
| Route | Oral | “A daily dose of 2 OmegaD softgels dosed orally BID will be compared to 2 placebo softgels dosed orally BID for 84 days.” NCT02980224 ↗ |